Trial Profile
Personalized medicine: Administration of TNF-alpha inhibitor treatment due to serum concentration measuring. A randomized and investigator initiated study.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2020
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 22 Mar 2019 This study has been completed in Denmark.
- 14 Jun 2017 According to a Biogen media release, data from this and other real-world studies were presented at the Annual European Congress of Rheumatology (EULAR) 2017.
- 16 Mar 2016 New trial record